TY - JOUR AU - Robati R AU - Mozafari N AU - Bidari-Zerehpoosh F AU - Niknejad N AU - Bizaval Z AB -
Lepromatous leprosy is associated with a high bacillary load and poor cellular immune response. Early dermatologic manifestations include erythematous macules, papules, nodules, and plaques with a symmetrical distribution. Leprosy also shows two major reaction states including type I (reversal reaction) and type II (vasculitis). These reactions are usually seen in some patients who are undergoing treatment. Herein, we report an interesting patient with lepromatous leprosy who presented with skin lesions of type II reaction without receiving any anti-leprosy treatment and surprisingly showed a type I reaction eight months after the beginning of the treatment.
BT - Dermatology online journal C1 - https://www.ncbi.nlm.nih.gov/pubmed/33054941 DA - 09/2020 IS - 9 J2 - Dermatol Online J LA - eng N2 -Lepromatous leprosy is associated with a high bacillary load and poor cellular immune response. Early dermatologic manifestations include erythematous macules, papules, nodules, and plaques with a symmetrical distribution. Leprosy also shows two major reaction states including type I (reversal reaction) and type II (vasculitis). These reactions are usually seen in some patients who are undergoing treatment. Herein, we report an interesting patient with lepromatous leprosy who presented with skin lesions of type II reaction without receiving any anti-leprosy treatment and surprisingly showed a type I reaction eight months after the beginning of the treatment.
PY - 2020 T2 - Dermatology online journal TI - Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment. UR - https://escholarship.org/uc/item/1f76n0b4 VL - 26 SN - 1087-2108 ER -